Ultima Vez Modificado: 4 de junio del 2007
Podcast of The "Opportunities in Proton Therapy" symposium from November 7, 2006. Worldwide cancer experts give you a unique opportunity to discover and share the information on the latest developments in Proton Therapy including dose distribution comparisons and anticipated gains, detailed clinical applications and trends in Proton Therapy care. Experience the collected knowledge of Nancy Mendenhall, MD and Tom DeLaney, MD as well as a host of other thought leaders in the exciting field of Proton Therapy.
iTunes Manual Instructions:
Also available as an on-demand webcast:
OncoLink TV: Opportunities in Proton Therapy
You may also use Quicktime to view the individual presentations.
Welcome and Introduction
Nancy Price Mendenhall, M.D., Professor, Associate Chair, and Medical Director, University of Florida Proton Therapy Institute, Jacksonville, FL
Rationale for Proton Therapy
Thomas F. DeLaney, M.D., Associate Professor of Radiation Oncology, Massachusetts General Hospital, Francis H. Burr Proton Therapy Center, Boston, MA
Bertil Damato, M.D., Hon. Professor of Ophthalmology, University of Liverpool, Ocular Oncology Service, St Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool UK
Norbert J. Liebsch, M.D., Ph.D., Assistant Professor of Radiation Oncology, Massachusetts General Hospital Cancer Center, Boston, MA
Claire Alapetite, M.D, Ph.D., Institut Curie, Radiation Oncology Department, Paris, and Institut Curie Centre de Protonthérapie d'Orsay, France
Nancy J. Tarbell, M.D., Professor of Radiation Oncology, and Director, Pediatric Radiation Oncology, Massachusetts General Hospital Cancer Center, Boston, MA
Head and Neck
Robert Malyapa, M.D., Assistant Professor, Department of Radiation Oncology, University of Florida Proton Therapy Institute, Jacksonville, FL
Liver – Yasuyuki Akine, M.D., Professor, Graduate School of Comprehensive Human Sciences (Radiation Oncology) and Director, Proton Medical Research Center Director, Department of Radiation Oncology, University Hospital University of Tsukuba, Japan
Takashi Ogino, M.D., National Cancer Center Hospital East, Kashiwa, Chiba, Japan
Yasuyuki Akine, M.D.
Gudrun Goitein, M.D., Head Division of Radiation Medicine, Paul Scherrer Institut, CH
5232 Villigen PSI, Switzerland
Carl J. Rossi, Jr., M.D., Loma Linda University Medical Center, Department of Radiation Medicine, Loma Linda, CA
Prostate (with Carbon)
Hiroshi Tsuji, M.D., Research Center for Charged Particle Therapy, National Institute of Radiology Sciences, Univ of Tsukuba, Japan
Allan F. Thornton, M.D., Midwest Proton Therapy Center, Bloomington, IN
Proton Therapy Pitfalls
Roundtable Discussion with Carl J. Rossi, Jr., M.D.,. Loma Linda University Medical Center, Department of Radiation Medicine, Loma Linda, CA; Thomas DeLaney, M.D.; and Gudrun Goitein, M.D.
Special Physics Issues
Thomas Bortfeld, Ph. D., Associate Professor of Radiation Oncology, Director of Physics Research, Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA
Special Physics Issues
Jatinder R. Palta, Ph.D., University of Florida Department of Radiation Oncology, University of Florida Proton Therapy Institute, Jacksonville, FL
C. Craig Tisher, M.D., Dean, College of Medicine, University of Florida, Gainesville, FL
Oct 23, 2014 - Patient surveys conducted in three time periods between 1995 and 2007 show that European countries are missing the opportunity to reduce cardiovascular disease through preventive efforts, according to an article published in the Mar. 14 issue of The Lancet.
Oct 23, 2014
Apr 18, 2012
May 24, 2011